Spineguard Stock

Spineguard EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of Spineguard (ALSGD.PA) as of Aug 9, 2026 is -8.40. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was -4.87 — a change of 72.40% (lower).

EV/FCF

-8.40

YoY

72.40%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of Spineguard is 2026 -8.40 . EV/FCF (Enterprise Value to Free Cash Flow) of Spineguard was 2025 -4.87 . It decreases by 72.40% lower compared to the previous year.
Access this data via the Eulerpool API

Spineguard Stock analysis

What does Spineguard do? SpineGuard SA is a French company that operates in the field of medical technology. The company was founded in 2009 and is headquartered in Paris. SpineGuard is a leading provider of instruments and devices to improve the precision and effectiveness of spinal surgeries. The company focuses on developing and marketing products in the field of spinal surgery, enhancing surgical instruments and devices to assist and facilitate surgeons in performing spinal operations. SpineGuard succeeds by bringing innovative products to the market, partnering with leading orthopedic companies, and addressing customer needs. The company offers a wide range of instruments and devices for spinal surgeries, including a bone slurper, vertebral body tensioner, and pedicle shaver. It has also developed the DSG (Dynamic Surgical Guidance) technology, which provides real-time feedback to surgeons during operations, improving surgical precision and reducing the risk of complications. SpineGuard operates in three areas: instrument and device development for spinal surgery, partnerships with leading orthopedic companies, and sales and marketing. The company constantly strives to improve its products and introduce new developments to the market. In conclusion, SpineGuard is an innovative company that focuses on improving surgical instruments and devices in spinal surgery. It has established a strong presence in the medical technology market with its wide range of products and technologies. By partnering with leading orthopedic companies and utilizing a dedicated sales and marketing team, SpineGuard aims to make its products accessible to a broader audience. The company is customer-focused and continually seeks to bring innovative products to market to enhance surgical precision and effectiveness. Spineguard is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Spineguard stock

EV/FCF (Enterprise Value to Free Cash Flow) of Spineguard is -8.40 in 2026.

EV/FCF (Enterprise Value to Free Cash Flow) of Spineguard changed from -4.87 to -8.40, representing a 72.40% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) Spineguard since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s Spineguard with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Spineguard

All Key Metrics — Spineguard